Arjun Vaidya's ~₹144 Crore Exit: Revitalizing a 150-Year Legacy into a D2C Powerhouse

Arjun Vaidya’s journey is a powerful testament to blending heritage with modern business acumen. He took a 150-year-old family legacy in Ayurveda, a promise made to his grandfather, and transformed it into Dr. Vaidya's, India's largest Ayurveda brand online, culminating in a pioneering D2C exit. His story is a masterclass in entrepreneurship, resilience, and the art of making ancient wisdom relevant for the 21st-century consumer.

This deep dive explores the story behind the brand, the strategies that fueled its growth, and the man who made it all happen. It’s a story he shared with incredible candor on the Founder Thesis podcast.

Check out the video of the conversation here or read on for insights

🌱 A Legacy Forged in Healing

The name ‘Vaidya’ literally means Ayurvedic doctor, and for Arjun’s family, it’s a name they have lived up to for six generations. The story begins not with Arjun, but with his great-grandfather, who moved to Mumbai from Gujarat in 1923 to practice Ayurveda. His grandfather later became one of Mumbai's most successful doctors, with his clinic seeing up to 350 patients a day and receiving letters from 12,000 more by post each month—the "old-time e-commerce."

Arjun’s connection to this legacy wasn’t just academic; it was deeply personal.

“I also grew up with juvenile bronchitis. So I started suffering from a really serious asthma, actually, at the age of two... I didn't have ice cream till I was twelve. I didn't have a colored beverage like a Coca-Cola or a Fanta... But Ayurveda actually helped me get rid of asthma completely. Twelve to fourteen years of treatment by my grandfather. Eventually, by age fourteen, fifteen, I was completely cured.”

This personal experience became the bedrock of his conviction. He wasn't just inheriting a business; he was a believer in the science that had changed his own life. As a teenager, he spent weekends with his grandfather, transcribing family formulations from old scriptures onto Excel sheets, informally promising to one day take the legacy forward.

🎓 From Brown University to LVMH's Private Equity Arm

After his schooling at The Cathedral & John Connon School and Dhirubhai Ambani International School, Arjun headed to Brown University in the USA. It was there that two key observations sparked an idea. He witnessed the explosion of the natural and organic products revolution and saw how yoga was being brilliantly "repackaged" for a modern audience.

“I had a Dutch friend of mine who was teaching me yoga, at Brown. And I thought that is crazy. It's cool. But also, what are we doing as Indians? You know, this is our heritage, and why didn't we give it to the world?... Why can't we be the people to do this with Ayurveda?”

After graduating with honors, Arjun returned to India and joined L Capital Asia (now L Catterton), the private equity arm of the luxury giant Louis Vuitton Moët Hennessy (LVMH). There, he analyzed over 150 consumer brands, gaining a priceless education in brand building, market dynamics, and the Indian consumer story.

But the corporate world wasn't his final calling. In 2013, his grandfather passed away. The clinic, a hub of healing for decades, was at risk of shutting down. This, combined with a moving conversation with his grandfather's long-serving nurse, became the catalyst. The promise he had made years ago resurfaced. In October 2016, Arjun Vaidya quit his job to revitalize his family's legacy.

🚀 Building Dr. Vaidya's: Making Ayurveda "Cool Again"

Arjun’s mission was clear: "repackage the ancient Indian science of Ayurveda for modern consumers." He started with a modest capital of just ₹1 lakh from his personal savings.

The company's initial strategy wasn't to launch dozens of traditional medicines. Instead, it focused on innovation and solving modern problems. The first two products were:

HerboFit: The goodness of Chyawanprash packed into a convenient daily capsule.
LIVitup: A hangover shield and liver protector, a product born from his grandfather’s writings about a formulation that helped with the after-effects of alcohol.

The Offline Failure & The D2C Pivot

Initially, Arjun tried to crack the offline retail market, hiring a sales team and distributors. The effort failed. Products sent to distributors were returned, and he quickly realized that without brand pull, simply placing a product on a shelf was not enough. In a difficult but crucial decision, he rolled back the offline strategy and, with his wife Trisha (who had experience from Nykaa's early team), pivoted to a D2C-first model, focusing intensely on their own website.

This decision was monumental. They scaled from one order every three days in late 2017 to celebrating 50 orders a day a year later.

📈 Scaling a D2C Powerhouse: The Growth Playbook

Dr. Vaidya's growth from that point was exponential. Here’s a snapshot of their key strategies and achievements:

Customer Base: Successfully reached over 2 million consumers.
Peak Orders: Scaled operations from zero to 5,000 orders per day.
Market Reach: Delivered products to over 16,500 pin codes across more than 500 cities in India.
Product Portfolio: Expanded the inherited repository of over 100 FDA-approved formulations by launching over 80 new products.
Digital Dominance: Became India's largest Ayurveda brand online, with its own website contributing up to 60% of sales even after scaling.
Tech-Driven Engagement: Innovatively used AI-powered chatbots to provide personalized product recommendations and 24/7 customer support, generating over 4,000 leads and handling 50,000+ customer queries.

Financial Growth Trajectory (Herbolab India Pvt Ltd):

FY 2017-18: ₹0.87 crore
FY 2018-19: ₹2.04 crore
FY 2019-20: ₹16.33 crore
FY 2022-23 (under RPSG): ₹30.1 crore

🤝 The Acquisition: A Pioneering D2C Exit

In June 2019, Dr. Vaidya's partnered with the RP-Sanjiv Goenka (RPSG) Group. CESC Ventures (later RPSG Ventures) acquired a majority stake, valuing the company at approximately ₹50 crore. This partnership provided the capital and resources to scale further.

By March 2021, RPSG Ventures acquired the remaining stake, leading to a full exit for the Vaidya family. This final transaction valued the company at approximately ₹144 crore, marking one of India's first and most successful D2C exits.

💡 From Founder to Investor: The V3 Ventures Thesis

Today, Arjun Vaidya is the Co-Founder of V3 Ventures, the venture investing arm of Verlinvest. He now invests in and mentors the next generation of early-stage consumer brands. His experience as a founder who has navigated the entire lifecycle—from a bootstrapped idea to a successful exit—provides him with a unique and invaluable perspective.

He identifies as a "founder first, then an investor," emphasizing principles of grit, resilience, and having no shortcuts. His journey with Dr. Vaidya's is not just a business case study; it's an inspiring saga of how to honor the past while boldly building the future.

Listen now!

Other ways to listen:

Apple Podcast | Amazon Music

Your Feedback matters

As always, I’d love to hear your thoughts! Whether it's about this episode or ideas you’ve been playing around with, shoot me an email at ad@thepodium.in. Your feedback keeps these conversations going, and I’m always up for chatting about your startup ideas too.

Until next time,

Your Host,

Akshay Datt

The Founder Thesis Podcast | Learn from disruptive founders

Arjun Vaidya's ~₹144 Crore Exit: Revitalizing…